Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Flad

<< Previous

Bullboard Posts

Next >>

Comment by Hound2010on Feb 03, 2021 9:50am

74 Views

Post# 32457150

RE:RE:RE:RE:RE:RE:Flad

Legally it is simple. You acquire a company you also inherit all debts, liens etc attached to the company. If I dont like the price I paid, as you would assume hexo did before the acquisition, then do not acquire the company. This isn't the grocery store with a price mat h policy. I do agree anything can happen in the legal system but this should be a slam dunk

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market